Proteomics Markets for Research and IVD Applications

By February 9, 2015Bitcoin Business
Click here to view original web page at

Proteomics Markets for Research and IVD Applications reflects Kalorama's market estimates, forecasts and competitive analysis of this important are. As part of its coverage, this report includes the following important data:
Proteomics Technologies, including: Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Bioinformatics, and Others, plus Discussion of Companies Commercializing Platforms Enabling Others to Use These Technologies
Applications of Proteomics, including: Research and Biomarker discovery, Drug Discovery and Development, and in Vitro Diagnostics (IVD)
Deals made by Proteomics Companies: Mergers, Partnerships, Investments
Consortia and Alliances in Proteomics
Proteomics Sales by Geographical Region, Worldwide, (North America, Europe, Asia, ROW)
Market Issues and Opportunities, Including Market Drivers for Immunoassays
Market Estimates for Mass Spectrometry in Proteomics and Forecast to 2018
Market Estimates for Chromatography in Proteomics and Forecast to 2018
Market Estimates for Microarrays in Proteomics and Forecast to 2018
Market Estimates for Electrophoresis in Proteomics and Forecast to 2018
Market Estimates for Immunoassays in Proteomics and Forecast to 2018
Market Estimates for IVD Applications of Proteomics
Market Estimates for Research Applications of Proteomics
Extensive Profiles of Companies
Product and Service Market Opportunity for Proteomics
The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Understanding the human proteome is a much larger and more challenging task than the Human Genome Project was. The proteome is much more complex as it can change based on factors that affect which genes are expressed. Also, after proteins are expressed, proteins may be modified. Proteomics will remain a very active area of research for several years, and the knowledge derived from this research is expected to produce advances in the diagnosis and treatment of diseases.r decades, many advances are being made in this field. Other major technology segments include chromatography, electrophoresis, microarrays, and other technologies.

Companies discussed in this report include those who with proteomics platforms and related products, commercializing technologies such as mass spectrometry or other proteomics technologies. In addition, this report discusses the proteomics research, services, and products developed and marketed by companies using these proteomics technologies and platforms. Many of the companies in this second group have developed their own proprietary proteomic technologies that utilize technologies such as mass spectrometry or other proteomic technologies.

Companies profiled in this report include:

Abbott Laboratories
AB SCIEX (A Danaher Corporation Company)
ActivX Biosciences, Inc. (Owned by Kyorin Pharmaceuticals)
Advion, Inc.
Affymetrix, Inc.
Agilent Technologies Inc.
Arbor Vita Corporation
ArcDia International Oy Ltd
Arrayit Corporation
Atonomics A/S
Avant Diagnostics, Inc.
Axela, Inc.
AXO Science
AYOXXA Biosystems GmbH
Banyan Biomarkers
Beckman Coulter, Inc.
(Subsidiary of Danaher Corporation)
Becton, Dickinson and Company (BD)
BG Medicine, Inc.
BioAnalyte Inc.
Biocartis SA
Biodesix, Inc.
Biognosys AG
bioMérieux SA
BioMosaics Inc.
Bioproximity, LLC
Bio-Rad Laboratories, Inc.
Biosensia Ltd.
BioSystems International
Bruker Corporation
Cambridge Protein Arrays Ltd.
Caprion, Inc.
caprotec bioanalytics GmbH
CardioGenics Holdings, Inc.
CD Diagnostics, Inc.
CDI Laboratories
Chromsystems Instruments & Chemicals GmbH
Clearbridge BioLoc Pte Ltd.
Courtagen Life Sciences, Inc.
CovalX AG
Crescendo Bioscience (Subsidiary of Myriad Genetics)
CyVek Inc.
Danaher Corporation
Dasit Group – Focusing on
DiAssess Inc.
Digilab, Inc.
Dualsystems Biotech AG
Euroimmun AG
Evotec AG
Expedeon, Inc.
Fujirebio Inc.
GE Healthcare Life Sciences
Genalyte, Inc.
GeneFluidics, Inc.
Geneva Bioinformatics (GeneBio) SA
GWC Technologies
Helena Laboratories
Hoefer, Inc. (Subsidiary of Harvard Bioscience, Inc.)
Hybrigenics SA
ImaBiotech SAS
Immunexpress Group
Immunovia AB
InDevR, Inc.
Insilicos LLC
Integrated Diagnostics, Inc.
Integromics S.L.
Intuitive Biosciences, Inc.
KineMed, Inc.
LEAP Technologies, Inc.
Life Technologies Corporation
LSI Medience Corporation
Luminex Corporation
MagArray Inc.
Matrix Science Limited
MBio Diagnostics, Inc.
Microlytic ApS
QuantiScientifics, LLC
Quidel Corporation
Rigaku Reagents, Inc.
Roche Diagnostics
Sebia, Inc.
Sera Prognostics, Inc.
Shimadzu Corporation
Siemens Healthcare Diagnostics
Sigma-Aldrich Corporation
Singulex, Inc.
SISCAPA Assay Technologies, Inc.
SomaLogic, Inc.
SpOtOn Clinical Diagnostics Limited
SQI Diagnostics Inc.
Syngene (Division of Synoptics Ltd)
T2 Biosystems, Inc.
Tecan Group AG
The Binding Site Group Ltd.
Theranostics Health Inc.
Thermo Fisher Scientific, Inc.
Tosoh Corporation
Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
Wako Diagnostics
Waters Corporation
Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +44 208 816 85 48

SOURCE ReportBuyer


More by this Source

Journalists and Bloggers

Leave a Reply

All Today's Crypto News In One Place